cp jaundice chapter vii

Upload: katherine-chingboo-leonico-laud

Post on 05-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 CP Jaundice Chapter VII

    1/25

    Chapter VII

    MEDICAL AND NURSING MANAGEMENT

    A. Ideal

    Medical Management

    Detection

    A physical exam is always important in assessing the level of jaundice.

    Jaundice first appears on the face, and, as the bilirubin level rises, spreads down

    the body. The yellow color is best appreciated in natural light, so doing the exam

    by a window is helpful.

    Tests that will likely be done include:

    Complete blood count

    Measurement of levels of specific types of bilirubin

    Reticulocyte count

    Treatment

    Phototherapy Phototherapy (light therapy) is the most common medical

    treatment for jaundice in newborns. In most cases, phototherapy is the only

    treatment required. It consists of exposing an infant's skin to a special blue light,

    which breaks bilirubin down into parts that are easier to eliminate in the stool and

    urine. Treatment with phototherapy is successful for most infants.

    http://www.righthealth.com/topic/Complete%20blood%20count?as=clink&ac=&afc=3626845248http://www.righthealth.com/topic/Complete%20blood%20count?as=clink&ac=&afc=3626845248http://www.righthealth.com/topic/Complete%20blood%20count?as=clink&ac=&afc=3626845248
  • 7/31/2019 CP Jaundice Chapter VII

    2/25

    Phototherapy is usually done in the hospital, but in select cases, it can be

    done in the home if the baby is healthy and at low risk of complications.

    Infants undergoing phototherapy should have as much skin exposed to

    the light as possible. Infants are usually naked (or wearing only a diaper) in an

    open bassinet or warmer, but wear eye patches to protect the eyes. It is

    important to ensure that lamps do not generate excessive heat, which could

    scald an infant's skin. In some institutions, phototherapy blankets are used.

    Phototherapy should be continuous, with breaks only for feeding.

    Phototherapy is stopped when bilirubin levels decline to a safe level. It is not

    unusual for infants to still appear jaundiced after phototherapy is completed.

    Bilirubin levels may rebound 18 to 24 hours after stopping phototherapy,

    although this rarely requires further treatment.

    - Side effects Phototherapy is very safe, but it can have temporary side

    effects, including a skin rash and loose bowel movements. Therefore, the

    infant's skin color, body temperature, and number of wet diapers are

    closely monitored

    Exchange transfusion Exchange transfusion is an emergency

    procedure that is done to prevent or minimize bilirubin-related brain damage. The

    transfusion replaces an infant's blood with donated blood in an attempt to quickly

    lower bilirubin levels. Exchange transfusion may be performed in infants who

    32

  • 7/31/2019 CP Jaundice Chapter VII

    3/25

    have not responded to other treatments and who have signs of or are at risk of

    bilirubin toxicity.

    Nursing Management

    Hydration It is important for infants receiving phototherapy to drink

    adequate fluids (breast milk or formula) since bilirubin is excreted in urine

    and bowel movements. Breastfeeding should continue during

    phototherapy, and in some cases, intravenous fluids may be necessary.

    Breastfeeding Breastfed infants who are not able to consume enough

    breast milk, whose weight loss is excessive, or who are dehydrated may

    need extra expressed breast milk or formula. Mothers who supplement

    with formula should continue to breastfeed or pump to maintain their milk

    supply.

    B. Actual

    Medical Management

    Date & Time Doctors Order Rationale

    September 15, 2010

    2:15 pm

    Wt= 3.1 kg

    Pls. admit under my

    service (ICU is

    possible)

    TPR q 4 hours &

    record pls.

    For management

    of neonatal jaundice

    For monitoring of

    the patients condition

    33

  • 7/31/2019 CP Jaundice Chapter VII

    4/25

    Continue

    breastfeeding.

    Pls. attach lab

    results to chart.

    Start with D5IMB

    500 mL @ 16-17

    cc/hr.

    Meds:

    Ampicillin 150 mg q

    12 hours IVTT.

    Gentamicin 15 mg

    OD IVTT.

    and physiologic

    status. This serves as

    the basis for further

    interventions to be

    given.

    To provide proper

    nutrition.

    Laboratory results

    serve as a basis for

    possible diseases

    associated with the

    patient.

    Helps to expand

    intravascular volume;

    corrects an underlyingimbalance in fluids

    and electrolytes, and

    compensates the loss

    in the body.

    To treat infection

    To treat infection

    34

  • 7/31/2019 CP Jaundice Chapter VII

    5/25

    September 15, 2010

    7:05 pm

    Pls. maintain temp.

    between 36.8-37.2C

    under droplight.

    Turn pt. to sides

    prone & supine

    position of 2 hours.

    To prevent

    increase in

    temperature

    To prevent

    occurrence of bed

    sores

    September 16, 2010

    jaundice

    Phototherapy q

    12 hours on 12 hours

    off

    For repeat b1, b2

    @ 6:00 am tomorrow

    Phototherapy is

    one of the treatments

    for neonatal jaundice.

    To diagnose any

    possible problem of

    patient.

    September 16, 2010

    UO- 50 cc

    IVF to 120 cc q 6 Increasing IVF will

    aid in decreasing fluid

    level of patient.

    September 17, 2010

    10:00 am

    7:20 pm

    Rebound jaundice after

    12 on & off exposure

    For continuous

    phototherapy

    For repeat CBC, B1

    and B2 @10:00 am

    tomorrow

    To treat neonatal

    jaundice

    To diagnose any

    problem related to the

    results of the patient.

    35

  • 7/31/2019 CP Jaundice Chapter VII

    6/25

    September 17, 2010

    4:00 pm

    IVF to ff D5IMB @

    120 cc q 6 in a

    soluset.

    Using soluset will

    monitor efficiently the

    fuid balance f the

    patient.

    September 18, 2010

    10:50 pm

    Pls. relay B1, B2 &

    CBC result once in.

    For the AP to

    study the result and

    diagnose problems of

    the patient.

    September 19, 2010

    9:00 pm

    jaundice

    D/C phototherapy

    refer for rebound

    jaundice.

    Resume full

    breastfeeding

    Vit. K, 1mg IM

    Jaundice was

    already reduced.

    To give proper

    nutrition.

    To enhance blood

    clotting.

    September 21, 2010

    9:30 am

    Complete 1 week

    course of antibiotics.

    To treat infections.

    Management Diagnostic Tests

    36

  • 7/31/2019 CP Jaundice Chapter VII

    7/25

    Urine Analysis

    Urine Analysis is the chemical analysis of a patient's urine. This laboratory

    test evaluates the physical characteristics (color, appearance, odor, opacity and

    turbidity) of patients urine. It also determines the specific gravity, presence of

    sugar and protein, types and amount of cells and crystals present.

    Date: September 15, 2010

    Physical Characteristics

    Color: Yellow

    Appearance: Clear

    Reaction: 5.0

    Specific gravity: 1.002

    Chemical Findings

    Sugar: (-)

    Protein: (-)

    Microscopic Findings

    Cells:

    Pus cells: 1-2/hpf

    RBC:0-1/hpf

    Crystals:

    Amorphous urates: Few

    Interpretation:

    Pus cells are identified in the sample urine of the patient. Pus cells

    37

  • 7/31/2019 CP Jaundice Chapter VII

    8/25

    indicate a urinary tract infection anywhere from the kidneys to the urethranis

    present. Cloudiness in urine may be caused by either pus or chemicals, a

    difference determined by simple laboratory tests. Presence of RBC in urine is

    due to: glomerular damage, tumors, kidney trauma, urinary tract stones, and

    urinary tract infections. Theoretically, no red cells should be found. Common

    crystals seen even in healthy patients include calcium oxalate, triple phosphate

    crystals and amorphous phosphates.

    Nursing Responsibilities:

    Explain to significant others how to collect a clean catch specimen of at

    least 15 mL.

    Obtain a first voided morning specimen if possible.

    BLOOD TYPING

    There are many RBC factors or types: the ABO group and the Rh factor.

    The ABO group contains four blood types: A, B, AB, and O. The Rh factor is

    another antigen. People whose RBCs have the Rh antigen are Rh positive; those

    without the antigen are Rh negative. The purpose of Blood typing is to determine

    what is the patients blood group and type.

    38

  • 7/31/2019 CP Jaundice Chapter VII

    9/25

    Interpretation:

    After testing the blood for blood typing, patient DongHae has been found

    out to be Rh positive. He also belongs in Blood type A group.

    HEMATOLOGY

    The word hematocrit means "to separate blood", a procedure which is

    done following the blood draw through the proper use of a centrifuge. Hematocrit

    is the measurement of the percentage of red blood cells in whole blood. It is an

    important determinant of anemia (decreased), polycythemia (increased),

    dehydration (elevated), increased R.B.C. breakdown in the spleen (decreased),

    or possible overhydration (decreased).

    Hemoglobin is the main transport of oxygen and carbon dioxide in the

    blood. It is composed of globin a group of amino acids that form a protein and

    heme which contains iron atoms and imparts the red color to hemoglobin. As with

    Hematocrit, it is an important determinant of anemia (decreased), dehydration

    39

    ABO & Rh BLOOD

    GROUP

    FORWARD TYPING BLOOD TYPE

    A +4 RH(+)

    B 0 A

    C +4

  • 7/31/2019 CP Jaundice Chapter VII

    10/25

    (increased), polycythemia (increased), poor diet/nutrition, or possibly a

    malabsorption problem.

    EXAM NAME RESULT UNIT NORMAL VALUES

    Hemoglobin 213 g/L 110-150

    Hematocrit 64 % 35-47

    RBC 7.1 X10^12/L 4.0-5.5

    WBC 5.0 X10^9/L 5.1-10

    -neutrophils 0.33 0.5-0.65

    -lymphocytes 0.5 0.25-0.40

    -monocytes 0.12 0.03-0.05

    -eusinophils 0.05 0.01-0.03-Platelet Count 250 X10^9/L 150-400

    Interpretation:

    Patient DongHae has been found to have high hematocrit level of 64, the

    normal range is 35-47 %. it usually indicates dehydration, but diminishes if

    normal fluid balance is restored. Some other infrequent causes of elevated

    hematocrit are lung disease, certain tumors, a disorder of the bone marrow

    known as polycythemia rubra vera. A low WBC count (leucopenia) may indicate

    bone marrow failure, possibly due to infection, tumor, fibrosis, presence of

    cytotoxic substance, collagen-vascular diseases (such as lupus erythematosus,

    disease of the liver or spleen), or radiation.

    Nursing Responsibilities:

    40

  • 7/31/2019 CP Jaundice Chapter VII

    11/25

    Explain to the significant others that the tests are done to detect any

    hematologic disorders

    Use gloves when collecting and handling all specimens.

    Transport the specimen to the laboratory as soon as possible after the

    collection.

    Do not allow the blood sample to clot, of the results will be invalid. Place

    the specimen in a biohazard bag.

    BLOOD CHEMISTRY

    A byproduct of the breakdown of hemoglobin from red blood cells in the

    liver, bilirubin is a good indication of the liver's function. Excreted into the bile,

    bilirubin gives the bile its pigmentation. Elevated in liver disease, mononucleosis,

    hemolytic anemia, low levels of exposure to the sun and toxic effects to some

    drugs, decreased levels are seen in people with an inefficient liver, excessive fat

    digestion, and possibly a diet low in nitrogen bearing foods.

    EXAM NAME RESULT UNIT NORMAL VALUES

    DBIL 0.47 H mg/dL 0-0.2

    TBIL 14.93 H mg/dL 0.2-1

    Indirect TBIL 14.46 H mg/dL 0.2-0.8

    Interpretation:

    41

  • 7/31/2019 CP Jaundice Chapter VII

    12/25

    When bilirubin levels are high, the skin and whites of the eyes may appear

    yellow (jaundice). Jaundice may be caused by liver disease (hepatitis), blood

    disorders (hemolytic anemia), or blockage of the tubes (bile ducts) that allow bile

    to pass from the liver to the small intestine. Too much bilirubin

    (hyperbilirubinemia) in a newborn baby can cause brain damage (kernicterus),

    hearing loss, and problems with the muscles that move the eye, physical

    abnormalities, and even death. Therefore, some babies who develop jaundice

    may be treated with special lights (phototherapy) or a blood transfusion to lower

    their bilirubin levels.

    Nursing Responsibilities:

    define and explain the test to the significant others

    state the specific purpose of the test

    explain the procedure

    discuss test preparation, procedure, and posttest care

    some blood chemistry tests will have specific requirements such as dietary

    restrictions or medication restrictions.

    CBC PLATELET COUNT

    This is done to aid in diagnosing anemia, certain cancers of the blood and

    monitor blood loss and infection. Also, to diagnose and/or monitor bleeding and

    clotting disorders.

    EXAM NAME RESULT NORMAL VALUES

    42

  • 7/31/2019 CP Jaundice Chapter VII

    13/25

    WBC Count 12.6 5-10x10 na/L

    -segmenters 0.30 0.55-0.65

    -lymphocytes 0.58 0.25-0.35

    -monocytes 0.08 0.03-0.06

    -eosinophil count 0.02 0.02-0.04-basophils 0.02 0.03-0.06

    Hemoglobin 180 140-170

    Hematocrit 0.54 0.40-0.50

    Platelet 345 150-350

    Interpretation:

    Patient DongHae has been found to have an increased level of White

    Blood Cells, which indicates an infection. Hemoglobin level is also slightly

    elevated, but can still be considered in normal level.

    Therapy

    Phototherapy is used as a primary treatment for Neonatal Jaundice and

    was used for Patient Baby DongHae until observed jaundice was reduced to near

    normal as possible.

    Pharmacologic Management

    43

  • 7/31/2019 CP Jaundice Chapter VII

    14/25

    Date ordered Name of Drug Dosage/ Order

    September 15, 2010

    2:15 pm

    Ampicillin 150 mg q12 IVTT

    Gentamicin 15 mg OD IVTT.

    September 16, 2010 Phototherapy q 12 hours on 12

    hours off

    September 19, 2010

    9:00 pm

    Vit. K 1 gm, IM

    DRUG STUDY

    44

  • 7/31/2019 CP Jaundice Chapter VII

    15/25

    Brand Name: Ampicillin

    Generic name: Ampicillin Sodium

    Classification: Anti-infectives; Penicillin

    Indications:

    Respiratory tract or skin and skin-structure infections.

    GI infections or UTIs.

    Bacterial meningitis or septicemia.

    Uncomplicated gonorrhea.

    To prevent endocarditis in patients having dental, GI, and GU procedures.

    Contraindications:

    Contraindicated in patient hypersensitive to drug or other penicillins.

    Use cautiously in patient with other drug allergies (especially to

    cephalosporins) because of possible cross-sensitivity, and in those with

    mononucleosis because of high risk of maculopapular rash.

    Dosage: 150 mg q120 IVTT

    Mechanism of Action: inhibits cell-wall synthesis during bacterial multiplication.

    Adverse Reactions:

    CNS: lethargy, hallucinations, seizures, anxiety, confusion, agitation, depression,

    dizziness and fatigue.

    CV: vein irritation, thrombophlebitis

    GI: diarrhea, nausea and vomiting, abdominal pain, glossitis, stomatitis, gastritis,

    enterocolitis, pseudomembranous colitis, black hairy tongue.

    45

  • 7/31/2019 CP Jaundice Chapter VII

    16/25

    GU: intestinal nephritis, nephropathy,vaginitis

    HEMATOLOGIC: anemia, thrombocytopenia, thrombocytopenic, purpura,

    eosinophilia, leukopenia, hemolytic anemia, agranulocytosis.

    SKIN: pain at injection site.

    OTHER: hypersensitivity reactions, overgrowth of nonsusceptible organisms.

    Nursing Responsibilities with Rationale:

    Assess patient about allergic reactions to penicillin. This is to prevent

    causing adverse reactions such as hypersensitivity.

    Obtain specimen for culture and sensitivity test before giving first dose.

    This is to identify if correct treatment has been initiated.

    Assess for any ampicillin rashes; a dull, red, itchy, flat or raised rashes.

    These signs and symptoms may indicate allergic reaction and need to

    stop the therapy.

    Assess sodium level because each gram of ampicillin contains 2.9 mEq of

    sodium.

    Assess for the adverse reactions that may occur. This is to prevent the

    casualties to worsen.

    Health Teaching:

    Instruct patient to report adverse reactions promptly.

    Tell patient to report discomfort at I.V. injection site.

    Advise patient to notify prescriber if a rash, fever, chills develops.

    Rationale: To treat infection

    46

  • 7/31/2019 CP Jaundice Chapter VII

    17/25

    Brand Name: Gentamicin

    Generic name: Gentamicin Sulfate

    Classification: Antibiotics; Aminoglyscoside

    Indications:

    Serious infections caused by sensitive

    strains of Pseudomonas aeruginosa, Escherichia coli, Proteus Klebsiella,

    or Straphylococcus.

    To prevent endocarditis before GI or GU procedure or surgery.

    Contraindications:

    Contraindicated to patients hypersensitive to drug or other

    aminoglycosides..

    Use cautiously in neonates, infants, elderly patients, and patient with

    impaired renal function or neuromuscular disorder.

    Dosage: 15 mg q80 IVTT

    Mechanism of Action: inhibits protein synthesis by binding directly to 30S

    ribosomal subunits; bactericidal.

    Adverse Reactions:

    CNS: dizziness, fever, headache, lethargy, encephalopathy, confusion, seizure,

    numbness, peripheral neuropathy, vertigo, ataxia, tingling.

    CV: hypotension

    GI: nausea and vomiting

    GU: nephrotoxicity, possible increase in urinary excretion of casts.

    47

  • 7/31/2019 CP Jaundice Chapter VII

    18/25

    HEMATOLOGIC: eosinophilia, anemia, leukopenic, thrombocytopenia,

    agranulocytosis.

    MUSCULOSKELETAL: muscle twitching, myasthenia gravis-like sybdrome.

    SKIN: rash, urticaria, pruritus, injection site pain.

    OTHER: anaphylaxis

    Nursing Responsibilities with Rationale:

    Obtain specimen for culture and sensitivity test before giving first dose.

    This is to identify if correct treatment has been initiated.

    Assess for sign and symptoms of superinfections(especially of upper

    respiratory tract), such as continued fever, chills and increased pulse rate.

    Signs of superinfection may indicate resistance to drug.

    Assess for anaphylaxis: rash, urticaria, pruritius, chills, fever or joint pains.

    These signs and symptoms may indicate allergic reaction and need to

    stop the therapy.

    Assess renal function before and during therapy: urine output, BUN, andcreatinine, monitor for nephrotoxicity.

    Health Teaching:

    Instruct patient to report adverse reactions promptly report adverse

    reactions, such as dizziness, vertigo,tingling or muscle twitching.

    Tell patient to report discomfort at I.V. injection site.

    Advise patient to notify prescriber if a rash develops or if Signs &

    Symptoms of superinfection occur.

    Rationale: To treat infection

    48

  • 7/31/2019 CP Jaundice Chapter VII

    19/25

    Brand Name: Vitamin K

    Generic name: Phytonadione

    Classification: Antihemorrhagic

    Indications:

    Recommended Dietary Allowance

    Hypoprothrombinemia caused by vitamin K malabsorption, drug therapy,

    or excessive vitamin A dosage.

    Hypoprothrombinemia caused by effect of oral anti coagulants.

    Contraindications:

    Contraindicated to patients hypersensitive to drug.

    Dosage: 1 mg IM

    Mechanism of Action: an antihemorrhagic factor that promotes hepatic formation

    of active coagulation factors.

    Adverse Reactions:

    CNS: dizziness

    CV: flushing, transient hypotension after I.V administration, rapid and weak

    pulse.

    SKIN: diaphoresis, erythema

    OTHER: anaphylaxis or anaphylactoid reactions, usually after excessively raid

    I.V administration; pain, swelling, and hematoma at injection site.

    Nursing Responsibilities with Rationale:

    49

  • 7/31/2019 CP Jaundice Chapter VII

    20/25

    Assess the label for administration route restriction.

    For I.M. use in adult and children, give in outer thigh or deltoid region.

    Subcutaneous route is preferred to avoid hematoma formation.

    With I.M or subcutaneous use, allergic reaction may occur.

    Monitor PT and INR to determine dosage effectiveness.

    If sever bleeding occur give fresh frozen plasma or whole blood

    immediately

    Watch for flashing, weakness, tachycardia, and hypertension; condition

    may progress to shock.

    For hemorrhagic disease in infants, phytonadione cause less adverse

    reaction that other vitamin K analogue.

    Health Teaching:

    Explain the purpose of the drug.

    Rationale: To prevent hemorrhagic disease of newborn.

    Nursing Management

    Encouraged the mother to continue breastfeeding Baby DongHae since

    bilirubin is excreted in urine and bowel movements. Breastfeeding should

    continue during phototherapy, and in some cases, intravenous fluids may

    be necessary.

    50

  • 7/31/2019 CP Jaundice Chapter VII

    21/25

    Monitored closely the patient especially the infant's skin color, body

    temperature, and number of wet diapers because phototherapy has side

    effects like loose bowel movement and skin rashes.

    Encouraged the mother to always secure Baby DongHae for his safety.

    Advised the significant others to follow and comply with the prescribed

    medication.

    PROGNOSIS

    51

  • 7/31/2019 CP Jaundice Chapter VII

    22/25

    The patients prognosis is fair because they were only able to seek

    medical assistance after 7 days. For most babies, jaundice usually resolves

    without treatment within 1 to 2 weeks. However, the parents were willing to

    comply for any treatment that will be given by the physician.

    52

    Poor

    Fair Good Justification

    Duration of

    Illness

    The patient manifested neonatal jaundice3 days after his birth; however, they seek

    for medical assistance only after 7 days.

    Onset The manifestation only took place 3 days

    after.

    PrecipitatingFactors

    It is good since there is no involvement ofany risk factor except that it is found to bea normal process happening on newborn.

    Willingness toCompliance of

    Treatment

    The patients mother is willing to complywith the treatment for the recovery of herson, thats why she follows what the

    physician is instructing her.

    Age

    His condition is common to almost 50% ofthe newborn and Baby DongHae is notaware of this because that he is stillyoung.

    Environment

    His parents see to it that his room isalways clean. However, external factorscan contribute in making it to be not totallyclean.

    Family Support

    Support system from his family is good

    since they show their love and care forBaby DongHae by always securing hissafety.

  • 7/31/2019 CP Jaundice Chapter VII

    23/25

    Discharge Planning

    General Condition of client upon discharge

    Upon discharge, the patient was lying and sleeping on his crib with her

    mother and other significant others around ready to be instructed with home

    instructions for the full recovery and improvement of the health status of Baby

    DongHae given by the student nurse.

    Method

    - Instructed the significant others to take the following home

    medication as ordered by the physician.

    - Explained to the significant others the drug names as well as the

    right route and dosage.

    - Informed the significant others about the side effects that may

    occur brought by the medication.

    - Encouraged the significant others to comply and follow religiously

    the right timing in taking the medication.

    Exercise/Environment

    53

  • 7/31/2019 CP Jaundice Chapter VII

    24/25

    - Instructed significant others to avoid risk factors that may harm

    Baby DongHae.

    - Encouraged significant others to always keep in mind of the

    safety and security of the patient.

    Treatment

    - Instructed to comply with the physicians prescribed medication

    such as the antibiotic to treat infections.

    Hygiene

    - Instructed significant others to bathe Baby DongHae everyday.

    - Advised significant others to change soaked diaper into new one.

    Outpatient

    - Advised significant others to visit or have a follow up check-up

    with the attending physician.

    - Advised to call and notify the attending physician for any

    abnormalities or complications that may further occur.

    Diet

    - Encouraged to continue breastfeeding.

    54

  • 7/31/2019 CP Jaundice Chapter VII

    25/25

    - Encouraged mother to eat nutritious foods that would help in her

    breastfeeding.